Financial reports
10-K
2023 FY
Annual report
15 Feb 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
10-K
2022 FY
Annual report
28 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
28 Feb 22
10-Q
2021 Q3
Quarterly report
3 Nov 21
Current reports
8-K
Departure of Directors or Certain Officers
29 Feb 24
8-K
Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value
15 Feb 24
8-K
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2023 Net Revenue Results
5 Jan 24
8-K
Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2023 Financial and Operational Results
2 Nov 23
8-K
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
21 Sep 23
8-K
Dr. Daniel G. Billen appointed Chair of the Board of Directors
21 Aug 23
8-K
Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2023 Financial and Operational Results
3 Aug 23
8-K
Aurinia Board of Directors Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
3 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
17 May 23
8-K
Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results
4 May 23
Registration and prospectus
S-8
Registration of securities for employees
26 May 23
S-3ASR
Automatic shelf registration
19 Nov 21
S-8
Registration of securities for employees
25 Jun 21
S-8
Registration of securities for employees
24 Feb 21
SUPPL
Supplemental materials (foreign)
23 Jul 20
SUPPL
Supplemental materials (foreign)
22 Jul 20
SUPPL
Supplemental materials (foreign)
26 Jun 20
F-10/A
Registration of securities (Canada) (amended)
17 Jun 20
S-8
Registration of securities for employees
9 Jun 20
F-X
Appointment of agent for service of process by issuers registering securities
29 May 20
Proxies
PX14A6G
Letter to shareholders
6 Jul 23
PX14A6G
Letter to shareholders
1 Jun 23
PX14A6G
Letter to shareholders
17 May 23
PX14A6G
Letter to shareholders
11 May 23
DEFA14A
Additional proxy soliciting materials
8 May 23
PX14A6G
Letter to shareholders
5 May 23
PX14A6G
Letter to shareholders
3 May 23
DEFA14A
Additional proxy soliciting materials
2 May 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
PX14A6G
Letter to shareholders
26 Apr 23
Ownership
SC 13D/A
ILJIN SNT Co., Ltd.
20 Mar 24
4
Peter Greenleaf
7 Mar 24
4
Joseph M Miller
7 Mar 24
4
Matthew Maxwell Donley
7 Mar 24
4
Scott Michael Habig
7 Mar 24
4
Stephen P. Robertson
7 Mar 24
4
Volker Knappertz
29 Feb 24
4
Volker Knappertz
22 Feb 24
4
Scott Michael Habig
22 Feb 24
4
Matthew Maxwell Donley
22 Feb 24